Objective:To observe the heart function、MEE and serum FFA of Shenqiyixin prescription for heart qi(yang)deficiency with blood stasis and fluid retention type of chronic heart failure patients,to evaluate the clinical...Objective:To observe the heart function、MEE and serum FFA of Shenqiyixin prescription for heart qi(yang)deficiency with blood stasis and fluid retention type of chronic heart failure patients,to evaluate the clinical efficacy and safety.Methods:64 cases with chronic heart failure of heart qi(yang)deficiency with blood stasis and fluid retention were randomly divided into two groups,3 cases were excluded,31 cases in the control group and 30 cases in the treatment group.The control group was treated with western medicine,and the treatment group was treated with Shenqiyixin prescription additionally.The course of treatment was 3 weeks.Observe the changes of TCM syndrome score,6MWD,LVEF,cESS,MEE,serum NTproBNP,serum FFA and safety indexes of each group before and after treatment.Results:after treatment,the TCM Syndromes of each group were improved.The total effective rate of the treatment group was 93.33%,and the control group was 83.87%.The treatment group was more effective(P<0.05).After treatment,the TCM syndrome score,cESS,MEE,NTproBNP and FFA of each group were decreased,6MWD and LVEF were increased(P<0.05),and the treatment group was superior to the control group(P<0.05).Conclusion:Shenqiyixin prescription can improve the TCM syndrome and heart function in patients with chronic heart failure of heart qi(yang)deficiency with blood stasis and fluid retention,at the same time,it can reduce the level of MEE and serum FFA in patients with heart failure.展开更多
目的:探讨火龙罐辅助治疗心肺气虚、血瘀饮停慢性心力衰竭(chronic heart failure,CHF)患者的效果。方法:选择2022年2月—2023年8月厦门市中医院心血管科确诊的120例心肺气虚、血瘀饮停CHF患者作为研究对象,按照随机数表法将患者分为两...目的:探讨火龙罐辅助治疗心肺气虚、血瘀饮停慢性心力衰竭(chronic heart failure,CHF)患者的效果。方法:选择2022年2月—2023年8月厦门市中医院心血管科确诊的120例心肺气虚、血瘀饮停CHF患者作为研究对象,按照随机数表法将患者分为两组,每组60例。对照组接受常规西医治疗,观察组在此基础实施火龙罐辅助治疗,比较两组治疗前后心功能分级、中医症候积分、明尼苏达心力衰竭生活质量问卷(Minnesota living heart failure questionnaire,MLHFQ)评分、N末端B型脑钠尿肽前体(N terminal pro B type natriuretic peptide,NT-proBNP)水平、临床效果及随访6个月再住院情况。结果:观察组治疗后心功能分级低于对照组,差异有统计学意义(P<0.05);观察组治疗后中医症候积分、MLHFQ评分、NT-proBNP水平低于对照组,且观察组治疗前后中医症候积分、MLHFQ评分、NT-proBNP差值大于对照组,差异有统计学意义(P<0.05);观察组临床效果优于对照组,差异有统计学意义(P<0.05);两组随访6个月再住院率比较,差异无统计学意义(P>0.05)。结论:火龙罐辅助治疗有助于改善心肺气虚、血瘀饮停CHF患者心功能分级、中医症候积分,提升生活质量,降低NT-proBNP水平,提高临床效果。展开更多
目的观察温针灸治疗阳气亏虚血瘀型慢性心力衰竭的临床疗效及对患者心功能和生活质量的影响。方法将60例阳气亏虚血瘀型慢性心力衰竭患者用随机数字表法分为对照组(30例)和研究组(30例)。两组均予内科常规基础治疗,对照组另予常规针刺治...目的观察温针灸治疗阳气亏虚血瘀型慢性心力衰竭的临床疗效及对患者心功能和生活质量的影响。方法将60例阳气亏虚血瘀型慢性心力衰竭患者用随机数字表法分为对照组(30例)和研究组(30例)。两组均予内科常规基础治疗,对照组另予常规针刺治疗,研究组另予温针灸治疗。观察两组治疗前后明尼苏达心功能不全生命质量量表(Minnesota living with heart failure questionnaire,MLHFQ)评分、6分钟步行试验(6-minute walk test,6MWT)结果、心功能指标[左室舒张末期内径(left ventricular end diastolic diameter,LVEDD)、左心室收缩末内径(left ventricular end systolic diameter,LVESD)和左室射血分数(left ventricular ejection fraction,LVEF)]以及血清肾素、醛固酮(aldosterone,ALD)、血管紧张素Ⅱ(angiotensinⅡ,AngⅡ)和血浆N末端B型利钠肽原(N-terminal pro-B-type natriuretic peptide,NT-proBNP)水平的变化,比较两组临床疗效。结果两组治疗后LVEDD、LVESD、肾素水平、ALD水平、AngⅡ水平、NT-proBNP水平和MLHFQ评分均较治疗前降低(P<0.05),LVEF和6MWT水平均较治疗前提高(P<0.05)。研究组治疗后LVEDD、LVESD、肾素水平、ALD水平、AngⅡ水平、NT-proBNP水平和MLHFQ评分均低于对照组(P<0.05),LVEF和6MWT水平均高于对照组(P<0.05)。研究组总有效率高于对照组(P<0.05)。结论在内科常规治疗基础上,温针灸治疗阳气亏虚血瘀型慢性心力衰竭的临床疗效优于常规针刺,可改善心脏功能,提高生活质量。展开更多
基金Natural Science Foundation of Heilongjiang Province(No.LH2019H104).
文摘Objective:To observe the heart function、MEE and serum FFA of Shenqiyixin prescription for heart qi(yang)deficiency with blood stasis and fluid retention type of chronic heart failure patients,to evaluate the clinical efficacy and safety.Methods:64 cases with chronic heart failure of heart qi(yang)deficiency with blood stasis and fluid retention were randomly divided into two groups,3 cases were excluded,31 cases in the control group and 30 cases in the treatment group.The control group was treated with western medicine,and the treatment group was treated with Shenqiyixin prescription additionally.The course of treatment was 3 weeks.Observe the changes of TCM syndrome score,6MWD,LVEF,cESS,MEE,serum NTproBNP,serum FFA and safety indexes of each group before and after treatment.Results:after treatment,the TCM Syndromes of each group were improved.The total effective rate of the treatment group was 93.33%,and the control group was 83.87%.The treatment group was more effective(P<0.05).After treatment,the TCM syndrome score,cESS,MEE,NTproBNP and FFA of each group were decreased,6MWD and LVEF were increased(P<0.05),and the treatment group was superior to the control group(P<0.05).Conclusion:Shenqiyixin prescription can improve the TCM syndrome and heart function in patients with chronic heart failure of heart qi(yang)deficiency with blood stasis and fluid retention,at the same time,it can reduce the level of MEE and serum FFA in patients with heart failure.
文摘目的:探讨火龙罐辅助治疗心肺气虚、血瘀饮停慢性心力衰竭(chronic heart failure,CHF)患者的效果。方法:选择2022年2月—2023年8月厦门市中医院心血管科确诊的120例心肺气虚、血瘀饮停CHF患者作为研究对象,按照随机数表法将患者分为两组,每组60例。对照组接受常规西医治疗,观察组在此基础实施火龙罐辅助治疗,比较两组治疗前后心功能分级、中医症候积分、明尼苏达心力衰竭生活质量问卷(Minnesota living heart failure questionnaire,MLHFQ)评分、N末端B型脑钠尿肽前体(N terminal pro B type natriuretic peptide,NT-proBNP)水平、临床效果及随访6个月再住院情况。结果:观察组治疗后心功能分级低于对照组,差异有统计学意义(P<0.05);观察组治疗后中医症候积分、MLHFQ评分、NT-proBNP水平低于对照组,且观察组治疗前后中医症候积分、MLHFQ评分、NT-proBNP差值大于对照组,差异有统计学意义(P<0.05);观察组临床效果优于对照组,差异有统计学意义(P<0.05);两组随访6个月再住院率比较,差异无统计学意义(P>0.05)。结论:火龙罐辅助治疗有助于改善心肺气虚、血瘀饮停CHF患者心功能分级、中医症候积分,提升生活质量,降低NT-proBNP水平,提高临床效果。
文摘目的观察温针灸治疗阳气亏虚血瘀型慢性心力衰竭的临床疗效及对患者心功能和生活质量的影响。方法将60例阳气亏虚血瘀型慢性心力衰竭患者用随机数字表法分为对照组(30例)和研究组(30例)。两组均予内科常规基础治疗,对照组另予常规针刺治疗,研究组另予温针灸治疗。观察两组治疗前后明尼苏达心功能不全生命质量量表(Minnesota living with heart failure questionnaire,MLHFQ)评分、6分钟步行试验(6-minute walk test,6MWT)结果、心功能指标[左室舒张末期内径(left ventricular end diastolic diameter,LVEDD)、左心室收缩末内径(left ventricular end systolic diameter,LVESD)和左室射血分数(left ventricular ejection fraction,LVEF)]以及血清肾素、醛固酮(aldosterone,ALD)、血管紧张素Ⅱ(angiotensinⅡ,AngⅡ)和血浆N末端B型利钠肽原(N-terminal pro-B-type natriuretic peptide,NT-proBNP)水平的变化,比较两组临床疗效。结果两组治疗后LVEDD、LVESD、肾素水平、ALD水平、AngⅡ水平、NT-proBNP水平和MLHFQ评分均较治疗前降低(P<0.05),LVEF和6MWT水平均较治疗前提高(P<0.05)。研究组治疗后LVEDD、LVESD、肾素水平、ALD水平、AngⅡ水平、NT-proBNP水平和MLHFQ评分均低于对照组(P<0.05),LVEF和6MWT水平均高于对照组(P<0.05)。研究组总有效率高于对照组(P<0.05)。结论在内科常规治疗基础上,温针灸治疗阳气亏虚血瘀型慢性心力衰竭的临床疗效优于常规针刺,可改善心脏功能,提高生活质量。
